138 related articles for article (PubMed ID: 12947137)
1. Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells.
Hetzel M; Walcher D; Grüb M; Bach H; Hombach V; Marx N
Thorax; 2003 Sep; 58(9):778-83. PubMed ID: 12947137
[TBL] [Abstract][Full Text] [Related]
2. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
Liu H; Zang C; Fenner MH; Possinger K; Elstner E
Breast Cancer Res Treat; 2003 May; 79(1):63-74. PubMed ID: 12779083
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1.
Fahmi H; Pelletier JP; Di Battista JA; Cheung HS; Fernandes JC; Martel-Pelletier J
Osteoarthritis Cartilage; 2002 Feb; 10(2):100-8. PubMed ID: 11869069
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.
Marx N; Froehlich J; Siam L; Ittner J; Wierse G; Schmidt A; Scharnagl H; Hombach V; Koenig W
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):283-8. PubMed ID: 12588772
[TBL] [Abstract][Full Text] [Related]
5. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
Naitoh T; Kitahara M; Tsuruzoe N
Cell Biol Toxicol; 2000; 16(2):131-5. PubMed ID: 10917568
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.
Galli A; Crabb DW; Ceni E; Salzano R; Mello T; Svegliati-Baroni G; Ridolfi F; Trozzi L; Surrenti C; Casini A
Gastroenterology; 2002 Jun; 122(7):1924-40. PubMed ID: 12055599
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
Konturek PC; Brzozowski T; Kania J; Kukharsky V; Bazela K; Kwiecien S; Harsch I; Konturek SJ; Hahn EG
Scand J Gastroenterol; 2003 May; 38(5):468-76. PubMed ID: 12795455
[TBL] [Abstract][Full Text] [Related]
8. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.
Marx N; Sukhova G; Murphy C; Libby P; Plutzky J
Am J Pathol; 1998 Jul; 153(1):17-23. PubMed ID: 9665460
[TBL] [Abstract][Full Text] [Related]
9. [Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome].
Luo YM; Wan XH; Jiang DQ; Kuang WY; Guo HB; Chen ZX; Wang HJ; Xie LH; Duan W
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):739-45. PubMed ID: 20021931
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
Yin Y; Hou G; Li ER; Wang QY; Kang J
Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages.
Ringseis R; Schulz N; Saal D; Eder K
J Nutr Biochem; 2008 Sep; 19(9):594-603. PubMed ID: 18155510
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone inhibits advanced glycation end product-induced TNF-α and MMP-13 expression via the antagonism of NF-κB activation in chondrocytes.
Chen C; Ma C; Zhang Y; Zeng Y; Li Y; Wang W
Pharmacology; 2014; 94(5-6):265-72. PubMed ID: 25471680
[TBL] [Abstract][Full Text] [Related]
13. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts.
Stewart D; Javadi M; Chambers M; Gunsolly C; Gorski G; Borghaei RC
BMC Mol Biol; 2007 Feb; 8():12. PubMed ID: 17319946
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Inhibits LPS-Induced Expression of PI3K/Akt, ERK, NF-κB, CX3CL1, and MMPs in Human Bronchial Epithelial Cells.
Jiang R; Wei L; Zhu M; Wu J; Wang L
Inflammation; 2016 Apr; 39(2):643-50. PubMed ID: 26635114
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
18. [Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats].
Qiao HM; Lu JR; Cheng HJ; Liu L; Ma QS; Fu WY; Zhao FX
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):591-4. PubMed ID: 16191269
[TBL] [Abstract][Full Text] [Related]
19. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
[TBL] [Abstract][Full Text] [Related]
20. Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
Panzer U; Schneider A; Guan Y; Reinking R; Zahner G; Harendza S; Wolf G; Thaiss F; Stahl RA
Kidney Int; 2002 Aug; 62(2):455-64. PubMed ID: 12110006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
